Total Payments
$5,140
2024 Payments
$170.17
Companies
40
Transactions
249
Medicare Patients
5,149
Medicare Billing
$981,356
Payment Breakdown by Category
Food & Beverage$4,545 (88.4%)
Education$594.96 (11.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,545 | 221 | 88.4% |
| Education | $594.96 | 28 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $649.23 | 28 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $460.80 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $407.62 | 18 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $372.57 | 13 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $372.32 | 21 | $0 (2019) |
| OPKO Pharmaceuticals, LLC | $266.91 | 15 | $0 (2023) |
| Amgen Inc. | $262.62 | 16 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $216.58 | 14 | $0 (2023) |
| Vifor Pharma, Inc. | $194.82 | 8 | $0 (2023) |
| CALLIDITAS THERAPEUTICS US INC. | $160.32 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $170.17 | 4 | CALLIDITAS THERAPEUTICS US INC. ($98.63) |
| 2023 | $980.41 | 41 | Mallinckrodt Hospital Products Inc. ($167.59) |
| 2022 | $1,089 | 47 | Aurinia Pharma U.S., Inc. ($295.49) |
| 2021 | $135.62 | 5 | Vifor Pharma, Inc. ($83.50) |
| 2020 | $573.92 | 25 | AstraZeneca Pharmaceuticals LP ($135.81) |
| 2019 | $814.40 | 46 | Otsuka America Pharmaceutical, Inc. ($197.50) |
| 2018 | $780.47 | 39 | Otsuka America Pharmaceutical, Inc. ($159.00) |
| 2017 | $596.77 | 42 | Mallinckrodt LLC ($149.81) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $98.63 | General |
| Category: Nephrology | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: NEPHROLOGY | ||||||
| 09/24/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/15/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $50.38 | General |
| Category: Renal Denervation System | ||||||
| 10/31/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/31/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.30 | General |
| 08/30/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $8.05 | General |
| 08/28/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $22.34 | General |
| 08/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardio-renal | ||||||
| 08/10/2023 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Hyperkalemia | ||||||
| 08/08/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 07/31/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/25/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Nephrology | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Nephrology | ||||||
| 07/10/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: NEPHROLOGY | ||||||
| 07/06/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $14.63 | General |
| 06/27/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Nephrology | ||||||
| 06/23/2023 | Bard Peripheral Vascular, Inc. | WavelinQ (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Vascular/Oncology | ||||||
| 06/19/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,346 | 3,031 | $518,639 | $253,112 |
| 2022 | 12 | 1,293 | 3,006 | $506,315 | $250,413 |
| 2021 | 12 | 1,195 | 2,844 | $454,824 | $232,305 |
| 2020 | 14 | 1,315 | 3,112 | $478,370 | $245,527 |
Total Patients
5,149
Total Services
11,993
Medicare Billing
$981,356
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 290 | 1,330 | $138,320 | $80,276 | 58.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 31 | 175 | $100,450 | $46,985 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 448 | 619 | $82,946 | $31,475 | 37.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 192 | 221 | $43,758 | $21,876 | 50.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 163 | $24,287 | $14,763 | 60.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 12 | 65 | $30,940 | $14,191 | 45.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 21 | 53 | $25,228 | $11,877 | 47.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $23,218 | $10,084 | 43.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 44 | $12,804 | $5,608 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 70 | $13,370 | $5,054 | 37.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 41 | 90 | $10,440 | $4,893 | 46.9% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 13 | 49 | $6,762 | $3,190 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 29 | 34 | $3,332 | $1,535 | 46.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Office | 2023 | 11 | 24 | $2,784 | $1,305 | 46.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 313 | 1,336 | $138,944 | $73,313 | 52.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 28 | 141 | $80,934 | $39,317 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 412 | 573 | $76,782 | $34,732 | 45.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 163 | 186 | $54,126 | $28,116 | 51.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 75 | 217 | $32,333 | $17,208 | 53.2% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 11 | 57 | $27,132 | $11,474 | 42.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 17 | 49 | $23,324 | $11,288 | 48.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 75 | 88 | $17,424 | $9,204 | 52.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $17,290 | $7,919 | 45.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 39 | 98 | $11,368 | $5,384 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 50 | $9,550 | $4,515 | 47.3% |
About Dr. Vivek Agarwal, M.D
Dr. Vivek Agarwal, M.D is a Internal Medicine healthcare provider based in Lima, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982918199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vivek Agarwal, M.D has received a total of $5,140 in payments from pharmaceutical and medical device companies, with $170.17 received in 2024. These payments were reported across 249 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($4,545).
As a Medicare-enrolled provider, Agarwal has provided services to 5,149 Medicare beneficiaries, totaling 11,993 services with total Medicare billing of $981,356. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology, Nephrology
- Location Lima, OH
- Active Since 07/29/2010
- Last Updated 03/09/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982918199
Products in Payments
- ACTHAR (Biological) $744.89
- JYNARQUE (Drug) $480.94
- LUPKYNIS (Drug) $239.90
- SAMSCA (Drug) $213.36
- LOKELMA (Drug) $180.81
- TARPEYO (Drug) $160.32
- FARXIGA (Drug) $160.29
- Auryxia (Drug) $155.88
- Velphoro (Drug) $153.93
- Rayaldee (Drug) $143.78
- Veltassa (Drug) $143.45
- INJECTAFER (Drug) $139.20
- GATTEX (Drug) $132.18
- RAYALDEE (Drug) $123.13
- Kerendia (Drug) $116.67
- XARELTO (Drug) $114.64
- FERAHEME (Drug) $102.13
- AURYXIA (Drug) $92.58
- NORTHERA (Drug) $86.92
- Parsabiv (Drug) $85.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lima
Dr. Jason Stienecker, D.o, D.O
Internal Medicine — Payments: $358,360
Internal Medicine $358,360
Sandeep Patel, Md, MD
Internal Medicine — Payments: $176,472
Internal Medicine $176,472
Jayde Kurland, Md, MD
Internal Medicine — Payments: $35,884
Internal Medicine $35,884
Kishore Nallu, M.d, M.D
Internal Medicine — Payments: $14,690
Internal Medicine $14,690
Dr. Scott Rinesmith, M.d, M.D
Internal Medicine — Payments: $13,019
Internal Medicine $13,019
Anil Muddada, M.d, M.D
Internal Medicine — Payments: $7,080
Internal Medicine $7,080